Navigation path

Pharmaceuticals - Community Register

  

Community register of orphan medicinal products


GRANTED  

Product information

Beta-artemether / lumefantrine (powder for oral suspension)

EU orphan designation number: EU/3/09/702   
Active ingredient: Beta-artemether / lumefantrine (powder for oral suspension)
Indication: Treatment of malaria
Sponsor: Dafra Pharma International NV
Slachthuisstraat 30/7,B- 2300 Turnhout, BelgiŽ

   Public summary of scientific opinion    

 

European Commission proceduresGoto top of the page

Close date procedure Procedure type EMEA number Decision summary publ decision docs annex
01/02/2010 Centralised Orphan - Designation EMEA/OD/110/09 (2010)662 of 28/01/2010